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Transketolase is a proven biocatalytic tool for asymmetric carbon-carbon bond formation,
both as a purified enzyme and within bacterial whole-cell biocatalysts. The performance of
Pichia pastoris as a host for transketolase whole-cell biocatalysis was investigated using
a transketolase-overexpressing strain to catalyze formation of L-erythrulose from b-
hydroxypyruvic acid and glycolaldehyde substrates. Pichia pastoris transketolase coding
sequence from the locus PAS_chr1-4_0150 was subcloned downstream of the methanol-
inducible AOX1 promoter in a plasmid for transformation of strain GS115, generating strain
TK150. Whole and disrupted TK150 cells from shake flasks achieved 62% and 65% conver-
sion, respectively, under optimal pH and methanol induction conditions. In a 300 lL reac-
tion, TK150 samples from a 1L fed-batch fermentation achieved a maximum L-erythrulose
space time yield (STY) of 46.58 g L21 h21, specific activity of 155 U g21CDW, product yield on
substrate (Yp/s) of 0.52 mol mol
21 and product yield on catalyst (Yp/x) of 2.23g g
21
CDW. We
have successfully exploited the rapid growth and high biomass characteristics of Pichia pas-
toris in whole cell biocatalysis. At high cell density, the engineered TK150 Pichia pastoris
strain tolerated high concentrations of substrate and product to achieve high STY of the chi-
ral sugar L-erythrulose. VC 2017 The Authors Biotechnology Progress published by Wiley
Periodicals, Inc. on behalf of American Institute of Chemical Engineers Biotechnol. Prog.,
34:99–106, 2018
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Introduction
Small molecule pharmaceuticals, comprising one or more
chiral centers, remain a major product type in modern medi-
cine, comprising two of the top five selling drugs globally in
2016, and five of the top 15.1 Optically pure synthesis of
small molecule pharmaceuticals by conventional chemi-
synthetic routes tends to require multiple steps, each of
which is typically defined by low product yield. As such,
complex small molecules with multiple chiral centers tend to
have high production costs due to the need for multiple
chemi-synthetic steps.
This challenge has led to the development of alternate
“toolbox” platforms2,3 including biological routes to con-
trolled, stepwise assembly of the chemical species required
to synthesize a final, desired molecule. Such biological
routes typically involve the application of enzymes in the
place of chemical catalysis, for “biocatalysis” to produce the
final compound, over one or more steps. One advantage of
enzymes is their promiscuity with respect to the molecules
they engage with as substrates, which can enable a given
enzyme to be used for a broad range of chemistries.4
Enzymes can also provide exquisite regio-, chemo-, and
stereo-selectivity for the synthetic steps they catalyze.
In comparison to chemi-catalytic conditions, which can
require extremes of pH and temperature, biocatalysis is
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typically performed in mild conditions; 258C-378C and pH 7.
Mild conditions can be cheaper to maintain than the harsher
conditions of chemi-catalysis. However, harsh conditions are
often unavoidable for upstream process steps such as the
conditioning of feedstocks to make them physically and bio-
logically compatible with downstream steps. Transitioning
from harsh to mild conditions between process steps typi-
cally requires further energy or material inputs and brings
significant cost implications.5 Purified enzymes are often
active in only mild conditions, but variants can be sourced
or engineered that are stable to extremes.6 However, even
robust enzyme variants have no capacity to regenerate them-
selves, as they inevitably accumulate damage and denatur-
ation over time. One option to make enzymes both self-
renewing and tolerant to non-mild conditions is to deploy
them while they are still sequestered within a host cell, so-
called whole cell biocatalysis.
Escherichia coli (E. coli) remains a popular option for
whole cell biocatalysis, due to its genetic tractability, robust-
ness, and rapid growth. However, E. coli is vulnerable to
lysis by bacteriophage, which are naturally ubiquitous in the
environment7 and therefore also in agricultural feed streams.
E. coli cells also undergo increasingly lethal cell stress from
below pH 5.58 and above pH 8.9 A broad variety of alterna-
tive host cells have thus been characterized for their perfor-
mance as whole cell biocatalysts.10 Yeasts are a major
alternative, with no pathogens equivalent to bacteriophage
and a broader range of pH tolerance, from pH 3 to pH 7.11
In addition to robustifying a biocatalytic step, whole cell
biocatalysis can also enable assembly of multiple enzymes
within a single component, the cell, to achieve complex,
multi-stage synthesis.12 These pathway engineering
approaches mean that biological routes are emerging as credi-
ble alternatives to chemi-synthesis for production of an ever-
increasing number of small molecule product classes, from
biofuels to pharmaceuticals. Engineered pathways can be
“hosted” by a cell, or steps taken to integrate some or all of
the pathway into the native metabolic networks of the host
cell. In the former approach typically lower value, achiral
compounds are fed to the host cell and converted to higher
value chemicals with defined chiral centers.13 In the latter
approach, often termed metabolic engineering, the cells need
only be cultivated using a cheap carbon source, often crude
waste streams from agriculture, and they will in effect convert
this material to a product of higher value, such as a biofuel.14
A particular class of enzymes known as transketolases
(EC 2.2.1.1) have been investigated as biocatalytic tools due
to their ability to form the asymmetric carbon-carbon bonds
commonly required for chemical synthesis of a broad range
of pharmaceuticals, agrochemicals, materials, and food ingre-
dients.15 In nature transketolases require thiamine diphos-
phate as a cofactor and provide a regulatory function in
cellular metabolism, linking the pentose phosphate pathway
to glycolysis by catalyzing transfer of a two-carbon fragment
from xylulose to ribose sugars, forming heptulose sugars.
Biotechnologists have shown that this activity can be
exploited to drive an irreversible reaction when providing b-
hydroxypyruvate (HPA) as the donor of the two-carbon frag-
ment, resulting in carbon dioxide as one of the reaction
products. Transketolases have typically been sourced from
genomic data mining of yeasts16 and bacteria17 and used for
production of a number of different products including food
flavorings, and synthetic precursors of chiral amino alcohols
which are valuable intermediates in synthesis of small
molecular therapeutics.18
The stereospecificity and enantioselectivity typical of
transketolases often results in bio-catalyzed reaction routes
that are more atom-efficient than their chemo-catalytic coun-
terparts for a given synthesis step.19 Key measures used to
assess the efficacy of a given transketolase system for bioca-
talysis are activity, substrate-specificity, and inhibition by
products or substrates. If necessary to achieve sufficient con-
version, the cost of enzyme purification can also be a key
performance measure. E. coli transketolase has been reported
to be effective in production of L-erythrulose when in solu-
tion,20 immobilized within a microreactor17 and within living
E. coli cells.21
The methylotrophic budding yeast, Pichia pastoris (P. pas-
toris), is an established laboratory-scale recombinant protein
production platform22 and is gaining traction as an industrial-
scale platform for production of enzymes23 and therapeutics.24
Characteristically low specific yield does not prevent high vol-
umetric yields of recombinant protein25 as P. pastoris can
grow rapidly to high biomass concentration, with 40% v/v
WCW typically achieved. Methylotrophic yeasts have also
been observed to tolerate extreme overexpression of the alco-
hol oxygenase 1 (Aox1p) enzyme essential for methanol utili-
zation, to a level where 30% of cell biomass can be taken up
with this enzyme during growth phase.26
The effectiveness of P. pastoris as a whole cell biocatalyst
has been investigated for ester biosynthesis,27 acetophenone
reduction.28 D-Amino acid oxidation29 and kinetic resolution
of racemic a-methylbenzylamine to 99% ee (R)-a-methyl-
benzylamine.13 A cell-surface display strategy has also been
used for expression of active lipase by a P. pastoris whole
cell biocatalyst.30
Previous work showed that overexpression of a native
transketolase within an E. coli whole cell biocatalyst could
achieve asymmetrization of the prochiral compounds b-
hydroxypyruvate (HPA) and glycolaldehyde (GA) to gener-
ate up to 20 mM L-erythrulose (ERY), for subsequent steps
in a de novo biocatalytic pathway, over a 17.5 h reaction
period.21 In this study, we sought to establish if the same
asymmetrization could be achieved using P. pastoris cells
overexpressing a native transketolase. We also wished to test
if the higher biomass achievable in P. pastoris could be har-
nessed to achieve higher levels of ERY production compared
to the E. coli whole cell biocatalyst.
Materials and Methods
Construction of the TK150 native transketolase
overexpressor strain
All DNA manipulations, unless otherwise stated, were per-
formed using standard molecular biology techniques. The
genome of P. pastoris strain GS115 (Invitrogen, Carlsbad,
CA), recently assigned31 as Komagataella phaffii (ATCC
20864), encodes a transketolase (TK) open reading frame
(ORF) at locus PAS_chr1–4_0150 (Genbank: CAY67980.1).
A single colony of P. pastoris strain GS115 was boiled in
water to provide genomic DNA template for preparative
polymerase chain reaction (PCR). Primers CACAATGTCT-
GATCTCTTAGC (start codon underlined) and AAA-
CTACGCATGAACAGACTC (stop codon underlined) were
provided by Eurofins MWG Operon (Ebersberg, Germany)
and used to PCR-amplify a 2.04 kb fragment from the
PAS_chr1–4_0150 locus32 encoding the TK ORF. The resul-
tant PCR fragment was subcloned into the pCR-BluntII-
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TOPO vector (Invitrogen) between a pair of Eco RI restric-
tion sites and its identity confirmed by sequencing. The TK
ORF fragment was then subcloned from pCR-BluntII-TOPO
into the P. pastoris expression vector, pAO815 (Invitrogen),
by non-directional ligation into a lone Eco RI site and a
Hind III digest used to confirm orientation. The resultant
plasmid, designated pAOX0150-TK, was linearized with the
restriction enzyme Stu I and used to transform P. pastoris
GS115 following manufacturer’s instruction.33 Successful
transformation generated a new strain, designated TK150, in
which the methanol utilization phenotype was preserved as
Mut1 and the histidine biosynthesis phenotype was con-
verted from His4 to HIS4.
Shake flask cultivation
Cells were typically cultivated in 50 mL buffered glycerol
complex medium (BMGY) broth (1% w/v yeast extract, 2%
w/v peptone, 100 mM potassium phosphate pH 6, 1.34% w/
v yeast nitrogen without amino acids, 1% v/v glycerol, and
0.4 mg/mL biotin) in a 250 mL shake flask incubated at
308C, with 250 rpm agitation for 15 h, after which an
OD6005 2 was reached. Glycerol stocks for cell cryopreser-
vation were made by pelleting cells at OD6005 2 by centri-
fugation at 13,000 rpm (Eppendorf 5415R centrifuge,
Eppendorf UK, Ltd, Cambridge, UK) for 5 min at room tem-
perature and resuspending cells in a solution of 5 volumes of
BMGY plus 3 volumes of 80% glycerol, then transferring
1.5 mL aliquots into 2 mL cryo-vials. Working cell banks
(WCB) of 20–30 vials were generated for each strain. Typi-
cally, 100 mL of BMGY medium in a 250 mL conical flask
were inoculated with 1 mL of a glycerol stock. For investi-
gation of recombinant TK activity, cells were grown to
OD6005 2 then pelleted as before. To induce expression of
TK under control of the AOX1 promoter, cells were resus-
pended again to OD6005 2 in buffered methanol (BMMY)
complex medium (recipe as BMGY but 1% v/v glycerol
substituted for 0.5% v/v methanol) and incubated as above
with pure methanol added to 0.5% v/v every 24 h post-
induction initiation.
Bioreactor cultivation
A 100 mL culture of TK150 cells in BMGY media in
500 mL shake flasks was incubated at 308C with agitation at
250 rpm until OD6005 80 was achieved. 40 mL of this cul-
ture were used to inoculate 600 mL of fermentation basal
salts medium (BSM) containing 4% w/v glycerol, to give an
initial OD600 of 5 in a 1L Infors bioreactor (Multifors 1,
INFORS HT, Switzerland). BSM consisted of 26.7 mL 85%
w/v H2PO4, 0.93 g CaSO4, 18.2 g K2SO4, 14.9 g
MgSO4.7H2O, 4.13 g KOH, 40 g glycerol, and 12 mL
“Pichia Trace Metal 1” (PTM1) solution (6.0 g/L
CuSO45H2O, 0.08 g/L Nal, 3.0 g/L MnSO4.H2O, 0.2 g/L
Na2MoO4.2H2O, 0.02 g/L H3BO3, 0.5 g/L CoCl2, 20.0 g/L
ZnCl2, 65.0 g/L FeSO4.7H2O, 0.2 g/L biotin, and 5.0 mL/L
96% H2SO4) per liter dH2O. During this initial trophophase
of glycerol batch growth, a dissolved oxygen set point of
20% was used for control of pure oxygen feeding. Bioreactor
cultivation was performed as per Invitrogen protocol.29
Three rates of methanol feed were introduced for induction,
3.6 mL/h/L initially (M1), then 7.3 mL/h/L (M2), and a final
feed rate of 10.9 mL/h/L (M3).
Preparation of solutions of whole and disrupted cells for
biocatalysis
Bioreactor and shake flask samples were centrifuged at
13,000 rpm for 20 min at 48C to pellet cells. Whole cells
were re-suspended in pH 7 Tris buffer and placed on ice to
inhibit further growth. A Soniprep 150 sonicator (MSE, Lon-
don, UK) was used to subject samples to a 10 s cycle of
100% amplitude sonication, followed by 10 s rest, three
times.
Reaction conditions
A 100 lL solution containing whole cells or disrupted
cells was initially incubated with 15 lL of a 2.4 mM solu-
tion of the cofactor thiamine pyrophosphate and 15 lL of
9 mM MgCl2 at room temperature with constant shaking at
150 rpm for 20 min. 50 lL of hydroxypyruvate and 50 lL
of glycolaldehyde, both at 300 mM, were then added in
addition to 70 lL of 50 mM Tris buffer to a final reaction
volume of 300 lL and substrate concentration of 50 mM.
Higher substrates concentrations, of up to 2 M, were
achieved by using the required volumes of 7 M stock solu-
tions of each substrate, again in a total final reaction volume
of 300 lL.
L-Erythrulose measurement
The Dionex HPLC system (Camberley, UK) and its moni-
tored software Chromeleon client 6.60 were used for reaction
analysis. The system contains an AD20 UV/vis absorbance
detector, a FAMOS autosampler, an oven and a GP50 gradi-
ent pump. A 15 min isocratic assay, as reported by Mitra
and Woodley,34 was used to analyze HPA and ERY, using a
300 mm 3 7.8 mm HPX-87H Reverse Phase Column (Bio-
Rad Amines, CA, USA). Mobile phase was prepared with
0.1% trifluoroacetic acid (TFA) and dH2O at a constant tem-
perature of 608C, flow rate 0.6 mL/min. Prior to analysis
samples were quenched and diluted into 10% in 0.1%v/v
TFA.
Results and Discussion
Growth and methanol tolerance of TK150 strain in shake
flasks
A novel P. pastoris GS115 strain, designated “TK150,”
was generated in which a native transketolase, encoded at
the locus CAY67980.1 (Genbank), was placed under the
control of the AOX1 promoter. Performance in shake flasks
achieved by the TK150 strain was comparable to that of the
parental strain in the presence of methanol (0.5% v/v) but
the TK150 strain achieved higher optical density (OD) from
day three post-induction onward (Figure 1). Nocon et al.35
showed that transketolase overexpression increased metabolic
flux in P. pastoris X-33 strain so we hypothesized transketo-
lase overexpression may also increase the capacity of P. pas-
toris to metabolize methanol. To test this hypothesis, we
cultivated TK150 and GS115 strains in 200 mL shake flasks
in 50 mL complex media (see Methods) supplemented with
methanol in concentrations of 0%, 0.25-1%, and 5% v/v.
Figure 2 shows that both TK150 and parental GS115 strains
grew to a similar level in the presence of 0.25-1% v/v meth-
anol. The highest concentration of 5% v/v methanol sup-
pressed completely growth of the parental GS115 strain but
still enabled growth of TK150, decreasing growth rate by
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half when compared to the supplementation of 0.25-1% v/v.
Interestingly, the TK150 strain also reached higher cell den-
sity than GS115 in the methanol-free condition.
Transketolase activity in whole and disrupted TK150 cells
We next established the profile of methanol-induced trans-
ketolase activity appearance in whole cells and cells dis-
rupted by sonication (Figure 3). Activity was measured by
percentage conversion of 50 mM HPA and GA substrates to
ERY. TK150 strain cells were grown in the absence of meth-
anol to OD6005 2 and from then onwards cultivated in the
presence of daily batches of methanol to 0.5% v/v. Figure 3
shows that, for the TK150 strain, transketolase activity
peaked at 48 h post-induction, as measured in both whole
cells and sonicates. For TK150 whole cells, conversion
remained within a 45–60% range for from 1 to 5 days post-
induction. This robustness in performance for whole cells
may be due to cellular homeostatic processes, such as
chaperone activity, working to maintain the folding and sta-
bility of cellular proteins during shake cultivation and incu-
bation with fed substrates. However, for disrupted TK150
cells conversion dropped dramatically at day three, down to
less than 10%. This steep drop might be due to the fact little
or no homeostatic activity is present in disrupted cells to
maintain protein stability during incubation with fed sub-
strates. No significant activity was observed for the parental
GS115 strain in the same experiments.
Transketolase activity across pH 5–9
Conditioning steps, such as adding solvents or altering
pH, are sometimes necessary to render a given feed stream
compatible with the addition of enzymes or whole cell bio-
catalysts in subsequent steps of a bioprocess. As such,
robustness to a range of pH values can be an industrially
advantageous property for biocatalysts. To investigate pH
Figure 1. Shake flask growth performance of P. pastoris
TK150 transketolase overexpressor strain. P. pasto-
ris strains GS115 or TK150 (TK) were cultivated in
250 mL shake flasks in 50 mL BMGY media. Sam-
ples were removed at the indicated time points and
OD600 measured. Error bars indicate standard devi-
ation among three biological repeats of the
experiment.
Figure 2. Methanol tolerance of the P. pastoris TK150 transketolase overexpressor strain. P. pastoris strains GS115 or TK150 (TK)
were cultivated in 250 mL shake flasks in 50 mL BMMY media supplemented with methanol (MeOH) to the percentage v/v
indicated. Samples were removed at the indicated time points and OD600 measured. Error bars indicate standard deviation
among three biological repeats of the experiment.
Figure 3. Transketolase activity of TK50 strain cultivated in
shake flasks. P. pastoris strains GS115 or TK150
(TK) were cultivated in 0.5% v/v methanol BMMY
media. At the indicated time points samples were
removed and prepared for incubation with 50 mM
b-hydroxypyruvate and 50 mM glycolaldehyde
either as whole (WC) or disrupted cells (Dis), as
described in Methods. The concentration of L-erythru-
lose produced was measured by HPLC and plotted as
a percentage of the starting concentration of substrates
(50 mM), as a level of conversion. Error bars indicate
standard deviation among three biological repeats of
the experiment.
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tolerance, we used whole cells and sonicates from 48-h
induction in shake flasks to determine optimal pH conditions
for bioconversion (Figure 4). We measured percentage con-
version of 50 mM HPA and GA to ERY in the presence of
buffers at a range of different pH values as indicated in Fig-
ure 4. Across pH 5–7, cell sonicates maintained their level
of activity in a phosphate buffer (Figure 4A). Using a Tris
buffer increased sonicate transketolase activity at pH 7 com-
pared to phosphate buffer. This high activity in Tris-based
buffer was maintained at pH 8 but decreased at pH 9.
Counter to our expectations, transketolase activity in
TK150 whole cells was much lower in phosphate buffer
across pH 5–7 (Figure 4B) compared to sonicates (Figure
4A). Furthermore, whole cell transketolase activity in phos-
phate buffer at pH 5 was completely abolished (0% conver-
sion) compared to the same condition for sonicates (70%
conversion). This observation was unexpected as Chiruvolu
et al.36 report significant P. pastoris cell growth at pH 5.
Sauer et al.37 measured an intracellular pH of 7.1 within P.
pastoris cells immersed in pH 5 growth media. Achieving
this intracellular pH control requires the employment of cel-
lular energy and mechanisms to drive reverse chemi-osmosis
across cell membranes. Such homeostatic processes may
compromise expression of the transketolase transgene, the
stability of the enzyme or the permeability of cell mem-
branes to the fed transketolase substrates, via as yet unchar-
acterized mechanisms. Further research in future will be
required to establish if such affects cause the abolished
activity at pH 5. The parental GS115 strain resulted in no
significant transketolase activity across the different pH con-
ditions (Figure 4).
Cultivation of TK150 strain to high cell density in a
bioreactor
A major advantage of P. pastoris for industrial application
is its ability to achieve higher levels of biomass, of up to
60% WCW/v, than the typical values obtained for E. coli or
Saccharomyces cerevisiae (S. cerevisiae). This can result in
high levels of a recombinant enzyme or protein per unit vol-
ume even if per cell yield is low.38 Consequently, we culti-
vated P. pastoris strain TK150 to high cell density and
measured the level of bioconversion achieved. Figure 5
details the typical growth profile observed during cultivation
of P. pastoris cells in a 1 L Infors bioreactor, reaching wet
cell weight (WCW) of 600 g/L using the cultivation regime
reported by Templar et al.39 Samples were taken immedi-
ately prior to the start of methanol feeding (indicated as M1
in Figure 5) and then 33 h and 58 h after the start of metha-
nol feeding.
Bioconversion by the TK150 strain at high cell density
To establish if the high biomass achievable by P. pastoris
can translate into enhanced biocatalytic performance,
Figure 4. Influence of pH and buffer choice on transketolase activity. P. pastoris strains GS115 or TK150 (TK) were cultivated in 0.5% v/v
methanol BMMY media as in Figure 3. Samples were removed and prepared for incubation with 50 mM b-hydroxypyruvate
and 50 mM glycolaldehyde either as whole (WC) or disrupted cells (Dis). During this preparation samples were resuspended in
either Tris (Tris) or Phosphate (Phos) buffer at the indicated final pH. Conversion of substrates to L-erythrulose was measured
and plotted as in Figure 3. Data set depicted is representative of three biological repeats of the experiment.
Figure 5. Bioreactor cultivation of TK150 strain to high cell den-
sity. Strain TK150 was grown in a bioreactor to high
cell density using a protocol in which methanol feeding
commenced at the point post-inoculation indicated by
the M1 bar. Methanol feed rate is stepped up at M2
and subsequently at M3. Wet cell weight (WCW) and
dry cell weight (DCW) for each sample are indicated
(see inset key). Samples taken at zero, 33 and 58 h
after the start of induction (M1) were used to test bio-
catalytic performance. Data set depicted is representa-
tive of three biological repeats of the experiment.
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samples taken from the Infors 1 L bioreactor at zero, 33 and
58 h post-induction were assessed for their volumetric activ-
ity in bioconversion of HPA and GA to ERY (Figure 6). For
whole cells, the greatest conversion percentage, nearing
65%, was achieved with the 33-h sample and with 0.5 M
substrates (Figure 6A). The highest amount of ERY pro-
duced was 776.4 mM, again with the 33-h post induction
sample but with a concentration of 1.5 M substrate provided
(Figure 6B). For sonicates, conversion fell relative to whole
cells, with the highest bioconversion level, of 38%, achieved
with the 58-h post-induction sample and 0.5 M substrates
(Figure 6C). The highest concentration of ERY produced by
sonicates was 110 mM, again with the 58-h post-induction
sample but with 1.0 M substrates (Figure 6D). A response
surface (Figure 7) was generated to map regions of high
whole cell bioconversion to ERY as a function of induction
period and substrate concentration. For cells harvested at
33 h post methanol induction, maximum conversion was
achieved upon feeding with 0.5 M substrates. For cells har-
vested at 58 h post methanol induction, maximum conver-
sion was achieved upon feeding with 1 M substrates. These
distinct maxima were not expected. In general, the percent-
age of viable cells decreases over the idiophase of high cell
density bioreactor cultivation. We suggest this viability dif-
ference between the 33 h and 55 h post induction samples is
likely to be a key determinant of the different performance
profiles. Future research will be needed to clarify this.
TK150 strain whole cell biocatalyst performance
Research into the usefulness of P. pastoris as whole cell
biocatalysts continues to accumulate, including the use of
killed40 or permeabilized41,42 whole cells. Schrewe et al.10
discuss a selection of performance metrics, distinct from
Figure 6. Effect of substrate concentration, cell density and induction period on TK150 strain whole cell biotransformation. Bioreactor
samples, taken at zero, 33 and 58 h post induction, were used to test biocatalytic performance for solutions of whole cells (A
and B) and cell sonicates (C and D). Percentage conversion of substrates to L-erythrulose (A and C) was plotted alongside
accumulation of L-erythrulose in molar and mass concentration terms (B and D). Error bars indicate standard deviation
among three biological repeats of the experiment. Key in plot B applies to all plots.
Figure 7. Response surface for TK150 strain whole cell biotransfor-
mation. Figure 6E data gathered for percentage conver-
sion of substrates to L-erythrulose (ERY) were plotted as
a function of both the time post-induction and the initial
substrate concentration present in the reaction mixture.
Average values were used to generate the response sur-
face. Standard deviation among three biological repeats
of the experiment is omitted for graphical brevity.
104 Biotechnol. Prog., 2018, Vol. 34, No. 1
those commonly applied for cell-free enzymes, to meaning-
fully characterize and compare whole cell biocatalysts. Table
1 shows a selection of Schrewe metrics for the biocatalytic
performance of the whole cells in this study, for the sample
taken 33 h post-induction. Ingram et al.21 constructed an E.
coli whole cell biocatalyst overexpressing native transketo-
lase for conversion of b-hydroxypyruvic acid and glycolalde-
hyde to L-erythrulose. They reported a maximum L-
erythrulose production of 20 mM after a 17.5 h reaction
duration. This equates to a STY of 13.7 mg L21 h21 which
is 3,400-fold lower than the activity of 46.58 g L21 h21 we
report here for P. pastoris whole cell biocatalysis.
Conclusions
The property of P. pastoris that already significantly bene-
fits its use in recombinant protein production, namely rapid
growth to high biomass, was also used here to intensify bio-
catalysis. A robust and novel recombinant P. pastoris whole
cell biocatalyst, TK150, overexpressing a native transketo-
lase gene was developed as a hosted, one-step biocatalytic
pathway to bring about asymmetric carbon-carbon bind for-
mation in the production of L-erythrulose from achiral sub-
strates. The P. pastoris whole cell biocatalyst remained
active from pH 7–9, and achieved performance metrics in
line with other P. pastoris-based biocatalysts and orders of
magnitude greater than a bacterial equivalent.
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